Page last updated: 2024-08-21

perflubron and Pneumonia, Viral

perflubron has been researched along with Pneumonia, Viral in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dieterich, HJ; Garofalo, RP; Gatalica, Z; Haeberle, HA; Nesti, F	1

Other Studies

1 other study(ies) available for perflubron and Pneumonia, Viral

Article	Year
Perflubron reduces lung inflammation in respiratory syncytial virus infection by inhibiting chemokine expression and nuclear factor-kappa B activation. American journal of respiratory and critical care medicine, 2002, May-15, Volume: 165, Issue:10 Topics: Administration, Intranasal; Analysis of Variance; Animals; Chemokine CCL5; Disease Models, Animal; Female; Fluorocarbons; Hydrocarbons, Brominated; Immunohistochemistry; Mice; Mice, Inbred BALB C; NF-kappa B; Pneumonia, Viral; Probability; Random Allocation; Reference Values; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; RNA, Messenger; Sensitivity and Specificity; Statistics, Nonparametric	2002

Article

Year

Perflubron reduces lung inflammation in respiratory syncytial virus infection by inhibiting chemokine expression and nuclear factor-kappa B activation.

American journal of respiratory and critical care medicine, 2002, May-15, Volume: 165, Issue:10

Topics: Administration, Intranasal; Analysis of Variance; Animals; Chemokine CCL5; Disease Models, Animal; Female; Fluorocarbons; Hydrocarbons, Brominated; Immunohistochemistry; Mice; Mice, Inbred BALB C; NF-kappa B; Pneumonia, Viral; Probability; Random Allocation; Reference Values; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; RNA, Messenger; Sensitivity and Specificity; Statistics, Nonparametric

2002